August 25, 2016 8:54 PM ET

Biotechnology

Company Overview of Geron Corporation

Executive Profile

Karin Eastham CPA, MBA

Independent Director, Chairman of Audit Committee and Member of Compensation Committee, Geron Corporation
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 13 different industries.

See Board Relationships
67$170,274

Background

Ms. Karin Eastham, CPA, MBA served as the Chief Operating Officer and Executive Vice President of Burnham Institute from May 2004 to September 2008. Ms. Eastham has over 25 years experience in financial and operations management, primarily in life sciences companies. She served as Senior Vice President of Finance, Chief Financial Officer and Secretary at Verenium Corporation from May 1999 to May 14, 2004 and also served as its Principal Accounting Officer until May 14, ...

Corporate Headquarters

149 Commonwealth Drive
Menlo Park, California 94025

United States

Phone: 650-473-7700
Fax: 650-473-7750

Board Members Memberships

2004-Present
Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2005-Present
Independent Director, Chairman of Audit Committee and Member of Compensation & Human Resources Committee
2008-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2009-Present
Independent Director, Chairman of Audit Committee and Member of Compensation Committee
2009-Present
Independent Director and Chairman of Audit Committee
2012-Present
Director, Chairman of Audit Committee and Member of Compensation Committee

Education

BS 1973
Indiana University, Bloomington
MBA 1979
Indiana University, Bloomington

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$215,500
Unexercisable Options$35,000
Total Number of Options$250,500

Total Compensation

Total Annual Cash Compensation$74,045
Total Calculated Compensation$170,274
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Olav Hellebø MBA, BBAChief Executive Officer and Director
ReNeuron Group plc
$405.0K
Richard J. Daly Chairman, Chief Executive Officer and President
Neuralstem, Inc.
--
Mark R. Weinreb M.S.Chairman, Chief Executive Officer and President
BioRestorative Therapies, Inc.
$600.0K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Geron Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.